Search results for "cell therapy"

Celltrion Secures Japanese Approval for Xolair and Eylea Biosimilars

Celltrion Secures Japanese Approval for Xolair and Eylea Biosimilars

Celltrion announced on the 27th that it has obtained marketing authorization from Japan’s Ministry of Health, Labour and Welfare for two key...
A Single Cancer Shot: Local Injection Triggers Systemic Tumor Disappearance

A Single Cancer Shot: Local Injection Triggers Systemic Tumor Disappearance

For decades, one immuno-oncology strategy has held immense promise while repeatedly falling short: the use of CD40 agonists.
A Joint Specialist’s 40-Year Insight: Weight, Muscle, and Posture Are the Three Pillars of Joint Health

A Joint Specialist’s 40-Year Insight: Weight, Muscle, and Posture Are the Three Pillars of Joint Health

Luxury cars, designer watches, and high-end fashion—to the truly wealthy, these are no longer the ultimate status...
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation

Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation

Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its...
The 'Frontline' Experience on an Uncharted Planet

The 'Frontline' Experience on an Uncharted Planet

"Why are you here, doctor?" "I wonder? I don't know either," I replied, smiling awkwardly as I took a sip of the drink...
Datroway Approved: New Targeted Therapy Offers Hope for Metastatic Breast Cancer

Datroway Approved: New Targeted Therapy Offers Hope for Metastatic Breast Cancer

A new therapeutic horizon has arrived for patients battling metastatic breast cancer that has progressed despite...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
Busan On Hospital to Introduce Proton Therapy: Expanding to Vietnam and Russia

Busan On Hospital to Introduce Proton Therapy: Expanding to Vietnam and Russia

Busan On Hospital has announced a bold new vision on the occasion of its 16th anniversary, aiming to establish a global...
VigenCell

VigenCell "Primary Endpoint Achieved"... Will a Domestic NK/T Lymphoma New Drug Be Born?

VigenCell has announced plans to apply for conditional approval within the year as it successfully completed...
Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer

Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer

Onconic Therapeutics announced on the 24th that its novel anti-cancer candidate, 'Nesuparib', has been designated as an...